Nebulization: A potential source of SARS-CoV-2 transmission

Respir Med Res. 2020 Nov:78:100778. doi: 10.1016/j.resmer.2020.100778. Epub 2020 Aug 4.

Authors

G Reychler¹, L Vecellio², J C Dubus³; 'group Aerosoltherapy GAT' of the French Language Respiratory Society-Société de Pneumologie de Langue Française SPLF

Affiliations

¹ Service de Pneumologie, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Bruxelles, Belgique. Electronic address: gregory.reychler@uclouvain.be.
² CEPR-INSERM U1100, Université de Tours, Faculté de Médecine, 37032 Tours cedex, France.
³ Pneumologie Pédiatrique, CHU Timone-Enfants, et Aix-Marseille Université, IRD, MEPHI, IHU Méditerranée-Infection, 13385 Marseille Cedex 5, France.

No abstract available

Keywords: Antifungal drugs; Azoles; Mucorales; Nebulization; Polyenes; Prophylaxis.

Publication types

Editorial

MeSH terms

Administration, Inhalation
Aerosols / adverse effects
COVID-19 / epidemiology
COVID-19 / transmission*
Cross Infection / epidemiology
Cross Infection / prevention & control
Disease Transmission, Infectious / prevention & control
Disease Transmission, Infectious / statistics & numerical data
Equipment Contamination / statistics & numerical data
Humans
Nebulizers and Vaporizers / virology*
Oxygen Inhalation Therapy / adverse effects
Oxygen Inhalation Therapy / methods
Pandemics
Respiratory Therapy / adverse effects*
Respiratory Therapy / methods
Risk Factors
SARS-CoV-2 / isolation & purification
SARS-CoV-2 / physiology*

Substances

Aerosols